ArticleJournal of medicinal chemistry2023

Discovery of a Hydroxylamine-Based Brain-Penetrant EGFR Inhibitor for Metastatic Non-Small-Cell Lung Cancer.

Jarvis Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.